Relmada Therapeutics is dedicated to improving the standard of care for central nervous system (CNS) disorders. Our primary focus is the mental health space as we advance our ongoing Phase 3 program of REL-1017, which aims to offer a revolutionary treatment for major depressive disorder (MDD).

Find the latest Relmada Therapeutics, Inc. (RLMD) stock quote, history, news and other vital information to help you with your stock trading and investing.

2 days ago · Relmada Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapies for central nervous system (CNS) and metabolic disorders. With a commitment to advancing breakthrough treatments, Relmada strives to improve patient outcomes and quality of life. For more information, visit www.relmada.com.

2 days ago · Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from Asarina Pharma AB Phase 2a results signaled ...

At Relmada Therapeutics, we focus on the research and development of transformative medicines for those living with central nervous system (CNS) disorders. Our company name stems from the word "relief" and represents our goal of providing curative treatments to patients living with CNS disorders.

2 days ago · Relmada Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapies for central nervous system (CNS) and metabolic disorders. With a commitment to advancing ...

Jan 21, 2025 · Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor...